🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

STARTING SOON: 09.11.2021 11AM(CET) #WHO tools for Verification of #HIV testing algorithms / Инструменты #ВОЗ для верификации алгоритмов тестирования на #ВИЧ WHO/Europe

With 8% of stillbirths worldwide attributable to syphilis, I’m proud of this MedAccess partnership with CHAI SD BIOSENSOR which will work to reduce serious negative outcomes of mother-to-child transmission of syphilis.

Attending the #ASLM2021 conference? Don't miss our discussion on #HIV & #syphilis testing in low- and middle-income countries: barriers, developments & how to protect mothers & newborns. ASLM World Health Organization (WHO) Ministry of Health- Uganda The Global Fund PEPFAR Federal Ministry of Health, NIGERIA MedAccess Michael Anderson

WHO releases new toolkit aslı to support quality HIV testing services Cheryl Case Johnson Emmanuel Fajardo Meg Doherty who.int/news/item/16-1…

Save the date for WHO's #ASLM2021 satellite on improving quality HIV testing and brand new tool kit bit.ly/3DqVJNB

Are you ready for International Testing week? Join us for an exciting session reporting on #COVID19 impacts on #HIV testing services. More information: coalitionplus.org/international-… #Testingisthekey #test4HIV Coalition PLUS

Maggie Barr-Dichiara sharing WHO guidance and priorities for affordable dual HIV/syphilis rapid tests for #EMTCT #test4HIV #ASLM2021

Uganda, one of the first countries to take WHO guidance to scale, shows success and power of dual HIV/syphilis testing in ANC, increasing syphilis testing by 32%. #test4HIV #ASLM2021

Strength in numbers: data, partners and leadership create resilient HIV services during COVID-19 in Zambia who.int/news-room/feat…

WHO & MedicinesPatentPool announce the first transparent, global, non-exclusive licence for a #COVID19 technology, after finalizing a licensing agreement with CSIC for a COVID-19 serological antibody technology. 👉 bit.ly/3nJQMtL

New systematic review of evidence highlights key challenges with “screen out tool” for HIV testing programmes bit.ly/3gGuGnR #test4hiv Jason Ong rachel baggaley Yannis Mameletzis (він/його) 🇺🇦🍉🕊🦠🧬 🎾 Hakim Ecrivain Public Martina Penazzato

.World Health Organization (WHO) #COVID19 #selftesting guidance is a game-changer for access to testing in LMICs & lays groundwork for self-testing in other diseases. High-quality, affordable self-tests can close the equity gap & help people keep themselves & their communities safe. who.int/publications/i…

WHO just published for the first time CONSOLIDATED guidelines on drug-susceptible #TB, also including a new recommendation on the use of a 4-month rifapentine-containing regimen (HPMZ) -- another first for TB! createsend.com/t/d-D008EFE5E3…

🆕 World Health Organization (WHO) #Monkeypox: important public health advice for gay, bisexual and other men who have sex with men who.int/publications/m…

'Sublicences with 3 manufacturers - potential to enable scale-up & implementation of CAB-LA for HIV prevention in long term' Meg Doherty AVAC who.int/news/item/30-0…

New article highlighting how HCV self-testing can increase the number of people tested, diagnosed, and cured. It's time to introduce HCVST are a cost-effective option in populations with high prevalence. bit.ly/434Tmxj PLOS Global Public Health rachel baggaley Unitaid FIND Meg Doherty

My new post: Why #Antibiotics Fail—And How We Can Do Better via Forbes forbes.com/sites/judyston… w thanks to Rodney E. Rohde, PhD "Doc R" for his #microbiology and #ClinicalLab perspective. #IDTwitter

1/Published this week in Lancet Global Health: underlining importance of making urine LAM testing available (together with sputum Xpert) for people living with HIV requiring hospital admission - to expedite TB diagnosis and treatment thelancet.com/journals/langl…

As Colombia considers issuing a compulsory license for a lifesaving HIV drug Dolutegravir, this infographic by MSF Access Campaign shows how compulsory license - a public health safeguard available to all countries - can help in increasing access to medicines.